CPA
REPL icon

Capital Performance Advisors’s Replimune Group REPL Stock Holding History

Capital Performance Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76
Closed -$833 – 2104
2024
Q3 		$833 Buy
+76
New +$772 ﹤0.01% 2003

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Capital Performance Advisors's REPL Position: Q4 2024 in Review

Capital Performance Advisors sold out of Replimune Group (REPL) in Q4 2024, closing a stake of 76 shares — an estimated $833 sold.

Capital Performance Advisors first reported a position in REPL in Q3 2024 and held it in 1 quarter. The position peaked at $833 in Q3 2024. 157 funds tracked by Wall St. Rank hold REPL as of Q4 2024.

  • Capital Performance Advisors reported no remaining Replimune Group position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 76 Replimune Group shares in Q4 2024, an estimated $833.
  • Capital Performance Advisors first reported a position in Replimune Group in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Replimune Group position peaked at $833 in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Replimune Group as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.